Update on the pathophysiology of psoriasis

Area of Science:

• Dermatology
• Immunology
• Genetics

Background:

• Psoriasis is a complex skin disease involving genetic predisposition, immune cells, and signaling molecules.
• Environmental factors can trigger psoriasis, initiating a cellular immune response.
• Key immune cells like T helper 1 (TH1) and T helper 17 (TH17) cells are activated by cytokines such as IL-12 and IL-23.

Purpose of the Study:

• To elucidate the underlying mechanisms of psoriasis pathogenesis.
• To highlight the role of immune signaling pathways in the disease.
• To discuss the impact of biologic therapies on psoriasis.

Main Methods:

• Review of the current understanding of psoriasis pathogenesis.
• Analysis of the immune response involving T cells and cytokines.
• Evaluation of the efficacy of biologic therapies targeting specific pathways.

Main Results:

• Psoriasis results from a genetically programmed interaction between skin cells and immunocytes, influenced by environmental stimuli.
• Activated TH1 and TH17 cells, stimulated by IL-12 and IL-23 from antigen-presenting cells (APCs), drive chronic inflammation.
• Cytokines like tumor necrosis factor (TNF)-α contribute to altered epidermal proliferation, differentiation, apoptosis, and neoangiogenesis, leading to characteristic skin lesions.

Conclusions:

• Biologic therapies targeting identified immunologic signaling pathways and cytokines have shown notable clinical improvement in psoriasis.
• Continued research into psoriasis pathogenesis is crucial for identifying novel therapeutic targets.
• Understanding the intricate interplay of genetic, environmental, and immunological factors is key to advancing psoriasis treatment.